Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
FIT Biotech Oy: FIT Biotech's financial calendar and Annual General Meeting in 2019 | ||
By: Nasdaq / GlobeNewswire - 14 Dec 2018 | Back to overview list |
|
FIT Biotech Oy FIT Biotech's financial calendar and Annual General Meeting in 2019
The Annual Report 2018 will be available on FIT Biotech's home pages (www.fitbiotech.fi) during the week 12/2019. FIT BIOTECH OY For further information: Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000 FIT Biotech in brief FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines. FIT Biotech applies its GTU® technology in its development projects, which at the time include gene-based treatments, genetic vaccines and research collaboration. Application areas include cancer (gene therapy) and infectious diseases such as HIV. FIT Biotech K-shares are listed on the First North Finland market maintained by Nasdaq Helsinki Ltd. DISTRIBUTION: |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |